Three months of rifapentine and isoniazid for latent tuberculosis infection. [electronic resource]
Producer: 20111220Description: 2155-66 p. digitalISSN:- 1533-4406
- Adult
- Antitubercular Agents -- administration & dosage
- Directly Observed Therapy
- Drug Administration Schedule
- Drug Therapy, Combination
- Follow-Up Studies
- Humans
- Intention to Treat Analysis
- Isoniazid -- administration & dosage
- Male
- Middle Aged
- Prospective Studies
- Rifampin -- administration & dosage
- Risk Factors
- Self Administration
- Tuberculosis -- drug therapy
- Virus Latency
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.